MedPath

Effect of oral pilocarpine in severe dry eye syndrome

Not Applicable
Conditions
dry eye syndrome
Registration Number
JPRN-UMIN000021268
Lead Sponsor
Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with following disease are excluded. myocardial infarction/ angina asthma/COPD infarction of digestive tract or cervix of bladder epilepsy Parkinson disease iritis previous allergic reaction to pilocarpine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ocular symptoms, fluorescein staining score, rose-bengal staining score, Schirmer test I, tear break up time, and tear clearance test after 1month of oral pilocarpine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath